secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2024-11-05T23:59:59+00:00
Accession:  0001104659-24-114376
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Novavax settles UK COVID vaccine supply dispute, agrees to pay $123.8M refund
-----------------------------------------------------------------------------

- Settlement with UK Health Security Agency resolves all claims related to the Amended and Restated Supply Agreement.
- Company to pay $123.8M in equal quarterly installments of $10.3M over three years, ending June 30, 2027.
- First installment of $10.3M due November 30, 2024 under a Letter of Amendment.
- Total includes $11.3M imputed interest; company may avoid interest by accelerating payments.
- Original supply agreement terminated effective November 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465924114376/0001104659-24-114376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465924114376/tm2427595d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-114376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer